Raises about Rs 11,000 crore via NCD private placement

Fund Raising View source PDF Explain this filing

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.5%Reaction day

₹4075.00

prior close

₹4105.00

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)-1.5%-0.9% vs market

Pharmaceuticals peers, median of 157sector-2.1%-0.4% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty 100 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.0

10m

-1.1

15m

-1.2

30m

-1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.5-1.5-0.9-2.1-0.4

Next day

-3.1-1.8-1.2-3.4+0.3

-1.3-1.2-0.1-2.0+0.7

-3.5-2.3-1.2-3.2-0.2

-2.5-1.8-0.7-3.5+1.0

-3.2-0.9-2.3-3.2+0.0

-3.0-1.1-1.9-2.2-0.8

15d

-0.6+1.6-2.2+1.1-1.8

+4.2+0.1+4.0-1.8+6.0

+4.9-9.2+14.1-8.0+12.9

+2.4-3.5+5.9-0.4+2.7

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Has allotted about Rs 10,996 crore of senior secured NCDs through private placement in 4 series. Tenures range from 2 to nearly 5 years, with coupons between 7.45 percent and 7.80 percent per annum. The 4 series are listed on the NSE wholesale debt market. Trademarks are pledged as collateral with 1.1x cover.

Likely market impact

Adds about Rs 11,000 crore of debt to the books; raises interest outflow but no equity dilution. Use of proceeds not disclosed.